Myers

Dave Myers, one-half of the Hairy Bikers TV presenting duo, died at the age of 66. He died two years after revealing his cancer diagnosis, as per Deadline. The much-loved star died "peacefully at home" yesterday, according to his Hairy Bikers co-star Si King, who posted a statement on social media. Dave Myers was surrounded by his wife and another close friend, when he died. Myers rose to prominence 20 years ago as a member of the Hairy Bikers, with Si King. They began by presenting The Hairy Bikers` Cookbook on the BBC…

Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, 2024.Bill Clark | Cq-roll Call, Inc. | Getty ImagesSenators will question the CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb on U.S. drug prices at a hearing Thursday, as lawmakers on both sides of the aisle work to rein in high health-care costs for Americans. The push to cut drug prices is one of those rare hot-button…

Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth. Here's what the company reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv:Earnings per share: $1.70 adjusted vs. $1.53 expectedRevenue: $11.48 billion vs. $11.19 billion expectedBristol Myers, one of the world's largest pharmaceutical companies, booked $11.48 billion in revenue…

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com. Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead. CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.It took subpoena…

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now and 2030, as blockbuster drugs will tumble off a so-called patent cliff.That refers to when a company's patents for one or more leading branded products expire, which opens the door for competitors to sell copycats of those drugs, often at a lower…

If there’s one thing horror movies have taught us, it’s that the taller the villains, the scarier they truly seem to be. While horror characters such as the Leprechaun and Chucky are running around like little ankle-biters causing unfathomable terror, some others make unsuspecting victims stop in their tracks and marvel at their towering stances. Then again, if you’re one of those eagle-eyed horror fanatics who specifically thirsts over the height of particular baddies, you’re probably itching to know how tall a slasher…

Easily one of the most legendary SNL stars of the 1990s is Mike Myers — the star and creator of numerous beloved SNL sketches, from “Wayne’s World” to “Coffee Talk.” However, you could say that his most unforgettable characters come from the big screen, like shag-a-delic spy Austin Powers or the titular ogre from the Shrek movies. Well, we decided to take a look at both Saturday Night Live and our favorite Mike Myers movies to find our picks for the comedian’s funniest quotes.(Image credit: NBC)"A Nerd Says, 'What?'" -…

A bunch of Star Trek movies are coming.Image: ParamountWhat’s available on Max January 1?The A-Team (2010)After Earth (2013)Alvin and The Chipmunks: The Squeakquel (2009)Body at Brighton Rock (2019)Cabin Fever (2003)Cabin Fever 2: Spring Fever (2009)Cyborg (1989)Dr. Strangelove Or: How I Learned to Stop Worrying and Love the Bomb (1964)I, Frankenstein (2014)It Comes At Night (2017)Jodorowsky’s Dune (2013)John Carpenter’s Escape From L.A. (1996)Machete (2010)Robocop (1987)Robocop (2014)Robocop 2 (1990)Robocop 3…

NEW YORK (AP) — Drugmaker Bristol Myers Squibb is acquiring Karuna Therapeutics, a biopharmaceutical company that has developed a new antipsychotic, in a $14 billion deal. Bristol Myers Squibb and Karuna announced their merger agreement on Friday. The transaction, which amounts to $330 per share in cash, offers a premium of 53% over Karuna’s stock on Thursday. The deal was unanimously approved by both companies’ boards of directors. Karuna’s top asset is KarXT, an experimental antipsychotic with a…

Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share.Karuna's stock popped more than 47% on the news Friday morning, hitting around $317 a share. Bristol Myers Squibb shares rose more than 3%.The deal will help expand Bristol Myers' drug pipeline after competition from a generic offering caused demand for the company's blood cancer drug Revlimid to tumble in its third quarter.The boards of directors at both Bristol Myers and…